FDA Approves Combined Diabetes, Cholesterol Pill

by VR Sreeraman on  October 8, 2011 at 1:58 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

FDA on Friday approved the first combined pill for those who suffer with the dangerous combination of diabetes and high cholesterol.
 FDA Approves Combined Diabetes, Cholesterol Pill
FDA Approves Combined Diabetes, Cholesterol Pill

Juvisync, which combines the medications of sitagliptin and simvastatin, "is the first product to combine a type 2 diabetes drug with a cholesterol lowering drug in one tablet," said Mary Parks, from the US Food and Drug Administration.

Previously both medicines were approved for use on prescription, the FDA said in a statement, adding some 20 million people in the United States suffer from type 2 diabetes, which is often linked to obesity.

"They often have high cholesterol levels as well. These conditions can lead to increased risk of heart disease, stroke, kidney disease and blindness... particularly if left untreated or poorly treated," the statement added.

Juvisync is manufactured by an Irish subsidiary of the US pharmaceuticals giant Merck.

Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Cholesterol High Cholesterol Drug Toxicity Vasectomy Heart Attack Diet Lifestyle and Heart Disease Body Mass Index Cholesterol - The Enigma Chemical Liposuction Heart Attack- Lifestyle Risks 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive